Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Obesity-Related Metabolomic Profiles and Discrimination of Metabolically Unhealthy Obesity Publisher Pubmed



Bagheri M1 ; Farzadfar F2 ; Qi L5 ; Yekaninejad MS3 ; Chamari M1 ; Zeleznik OA6 ; Kalantar Z4 ; Ebrahimi Z7 ; Sheidaie A2 ; Koletzko B8 ; Uhl O8 ; Djazayery A1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Community Nutrition, School of Nutritional Sciences and Dietetic, Tehran, 1416-643931, Iran
  2. 2. Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran, 1416-643931, Iran
  3. 3. Department of Epidemiology and Biostatistics, School of Public Health, Tehran, 1416-643931, Iran
  4. 4. Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetic, Tehran University of Medical Sciences, Tehran, 1416-643931, Iran
  5. 5. Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, 02115, MA, United States
  6. 6. Channing Division of Network Medicine, Harvard Medical School and Brigham, Women's Hospital, Boston, 02115, MA, United States
  7. 7. Department of Nutrition, Faculty of Health, Shahid Sadoughi University of Medical Sciences, Yazd, 8916-877391, Iran
  8. 8. Division of Metabolic and Nutritional Medicine, Dr. von Hauner Children's Hospital, Ludwig-Maximilians-Universitat Munchen, Munich, 80337, Germany

Source: Journal of Proteome Research Published:2018


Abstract

A particular subgroup of obese adults, considered as metabolically healthy obese (MHO), has a reduced risk of metabolic complications. However, the molecular basis contributing to this healthy phenotype remains unclear. The objective of this work was to identify obesity-related metabolite patterns differed between MHO and metabolically unhealthy obese (MUHO) groups and examine whether these patterns are associated with the development of cardiometabolic disorders in a sample of Iranian adult population aged 18-50 years. Valid metabolites were defined as metabolites that passed the quality control analysis of the study. In this case-control study, 104 valid metabolites of 107 MHO and 100 MUHO patients were separately compared to those of 78 normal-weight metabolically healthy (NWMH) adults. Multivariable linear regression was used to investigate all potential relations in the study. A targeted metabolomic approach using liquid chromatography coupled to triple quadrupole mass spectrometry was employed to profile plasma metabolites. The study revealed that, after Bonferroni correction, branched-chain amino-acids, tyrosine, glutamic acid, diacyl-phosphatidylcholines C32:1 and C38:3 were directly and acyl-carnitine C18:2, acyl-lysophosphatidylcholines C18:1 and C18:2, and alkyl-lysophosphatidylcholines C18.0 were inversely associated with MHO phenotype. The same patterns were observed in MUHO patients except for the acyl-carnitine and lysophosphatidylcholine profiles where acyl-carnitine C3:0 and acyl-lysophosphatidylcholine C16:1 were higher and acyl-lysophosphatidylcholines C18:1, C18:2 were lower in this phenotype. Furthermore, proline, and diacyl-phosphatidylcholines C32:2 and C34:2 were directly and serine, asparagines, and acyl-alkyl-phosphatidylcholine C34:3 were negatively linked to MUHO group. Factors composed of amino acids were directly and those containing lysophosphatidylcholines were inversely related to cardiometabolic biomarkers in both phenotypes. Interestingly, the diacyl-phosphatidylcholines-containing factor was directly associated with cardiometabolic disorders in the MUHO group. A particular pattern of amino acids and choline-containing phospholipids may aid in the identification of metabolic health among obese patients. © 2018 American Chemical Society.
Other Related Docs
10. The Association Between Sarcopenic Obesity (So) and Major Dietary Patterns in Overweight and Obese Adult Women, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2019)
32. Gut Microbiota-Derived Metabolites in Obesity: A Systematic Review, Bioscience of Microbiota# Food and Health (2020)